Looks good, but so do the orthodox and sede videos/documentaries..... You could have the same exact trailer for the FSSP. There is no need to leave the structure/discipline of the church, start a parallel hierarchy, disobey cannon laws and traditional Church teachings, try and guide your selves and do what the saints have never done! You can get the same exact thing from the FSSP (without the constant negative news about the crisis).....and although they are not perfect since no one is, they are fighting from within like all previous saints did during a crisis in the Church. The SSPX will make up or repeat lies about the FSSP and bash them so that people dont consider it, but I tell you, give your local FSSP a try and you will see there is another way to fight the crisis without giving up your faith.
They are definitely done after today no doubt! Red blood! Now there is a ticker with after hours ER that should be killer, $800 plus coming. Whoever out there is looking for a safe play with a quick 10% and more with margin, check out $CASY reporting ER after hours and historically has an 8% move on good earnings. For those who are tired of the crazy china plays $PAVS $MTEN $CCTG Bullish
@Paraboljoker Let's hit $SUGP tomorrow, it's the lowest in the market and it's been very volatile. It's at a low and it's Chinese to go with the theme. To be a massive runner tomorrow
@moonmarket Let's hit $SUGP tomorrow, it's the lowest in the market and it's been very volatile. It's at a low and it's Chinese to go with the theme. To be a massive runner tomorrow
I have a great one for you! This is such a clean ticker with a massive explosion coming up! $HUMA On June 11, 2026. Humacyte will present its V012 Phase 3 clinical trial readout for its Acellular Tissue Engineered Vessel (ATEV) in hemodialysis access live at the Vascular Annual Meeting Plus phase 3 showed good results, so likely this gets approved and going. Also, on May 20, 2026, a ''high-profile'' corporate director executed a large open-market share purchase, signaled by a Form 4 filing just weeks ahead of the critical Phase 3 presentation It has just about doubled since that executive buy, for a reason.
I have a great one for you! This is such a clean ticker with a massive explosion coming up! $HUMA On June 11, 2026. Humacyte will present its V012 Phase 3 clinical trial readout for its Acellular Tissue Engineered Vessel (ATEV) in hemodialysis access live at the Vascular Annual Meeting Plus phase 3 showed good results, so likely this gets approved and going. Also, on May 20, 2026, a ''high-profile'' corporate director executed a large open-market share purchase, signaled by a Form 4 filing just weeks ahead of the critical Phase 3 presentation It has just about doubled since that executive buy, for a reason.
@moonmarket $AKAN Sits with an extremely restricted float of 530,000 shares. It is highly prone to massive gapping windows - I am all in here, lets see some AH 100% spike.
@IllyrianSpartan $AKAN Sits with an extremely restricted float of 530,000 shares. It is highly prone to massive gapping windows - I am all in here, lets see some AH 100% spike.
@Paraboljoker $AKAN is the AH play today, I have many groups and discords in on this, load up a few minutes before close, with an extremely restricted float of 530,000 shares. It is highly prone to massive gapping windows, could see $40 plus. Good luck.
@thommic@greatstockpicks $AKAN is the AH play today, I have many groups and discords in on this, load up a few minutes before close, with an extremely restricted float of 530,000 shares. It is highly prone to massive gapping windows, could see $40 plus. Good luck.
@greatstockpicks $AKAN is the AH play today, with an extremely restricted float of 530,000 shares. It is highly prone to massive gapping windows, could see $40 plus. Good luck.
@greatstockpicks $AKAN is the AH play today, with an extremely restricted float of 530,000 shares. It is highly prone to massive gapping windows, could see $40 plus. Good luck.
@moonmarket@greatstockpicks $akan for AH today, spread the word. Sits with an extremely restricted float of 530,000 shares. It is highly prone to massive gapping windows
@moonmarket Dude, there is a chance, a big group is targeting this ah. $AKAN Sits with an extremely restricted float of 530,000 shares. It is highly prone to massive gapping windows - $40 PT, lets make that money back!